Pfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Data Shows
Source: Forbes
A booster dose of the Pfizer-BioNTech Covid-19 vaccine significantly improved protection from infection and serious illness among people who are older than 60, findings published by the Israeli Health Ministry on Sunday showed, a finding that will likely bolster the push for deploying a third dose of the vaccine to better protect elderly and immunocompromised populations.
Among people aged 60 and older, the health ministry’s findings showed that the booster dose offered a four-fold increase in protection from infection after 10 days compared to people who have received two doses, Reuters reported.
The third dose also offered five to six times stronger protection against hospitalization or serious illness after 10 days in the same age group.
Despite having one of the widest vaccine rollouts in the world, Israel has seen a major resurgence of Covid-19 inside its borders largely fueled by the more infectious delta variant.
Read more: https://www.forbes.com/sites/siladityaray/2021/08/23/pfizer-booster-significantly-lowers-risk-of-covid-19-infection-among-elderly-israeli-govt-finds/